wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38776701-F2D64956-FE64-4C0C-B5EC-58EB50B5D53B
Q38776701-F2D64956-FE64-4C0C-B5EC-58EB50B5D53B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38776701-F2D64956-FE64-4C0C-B5EC-58EB50B5D53B
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.
P2860
Q38776701-F2D64956-FE64-4C0C-B5EC-58EB50B5D53B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38776701-F2D64956-FE64-4C0C-B5EC-58EB50B5D53B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c1ed47c6e004b929c899b7511435f7af70faf7b4
P2860
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).